Maintenance 5-azacytidine therapy by MRD monitoring after allogeneic HSCT in myeloid/lymphoid neoplasms with FGFR1 rearrangement
暂无分享,去创建一个
N. Nakamura | K. Ohyashiki | T. Umezu | Kenko Azuma | J. Ohyashiki | D. Akahane | Hiroaki Fujimoto | S. Katagiri | T. Suguro | Nahoko Furuya | Chiaki Kobayashi